JV
Therapeutic Areas
nCage Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Synthetic VLP Vaccines | Respiratory Diseases | Pre-clinical |
| Antibody Drug Conjugates (ADCs) | Oncology | Pre-clinical |
Leadership Team at nCage Therapeutics
CK
Christopher Kaplan
Chief Business Officer & Co-Founder
JH
Jonathan Heddle, Ph.D., D.Sc.
Chief Scientific Officer